Cencora Inc. (COR)vsCosmos Health Inc. (COSM)
COR
Cencora Inc.
$286.13
-0.29%
HEALTHCARE · Cap: $55.67B
COSM
Cosmos Health Inc.
$0.19
-7.42%
HEALTHCARE · Cap: $10.69M
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 472909% more annual revenue ($328.68B vs $69.49M). COR leads profitability with a 0.8% profit margin vs -30.4%. COR earns a higher WallStSmart Score of 64/100 (C+).
COR
Buy64
out of 100
Grade: C+
COSM
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-58.6%
Fair Value
$180.37
Current Price
$286.13
$105.76 premium
Intrinsic value data unavailable for COSM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 75 in profit
Earnings expanding 128.3% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Generating 1.2B in free cash flow
Reasonable price relative to book value
Revenue surging 30.7% year-over-year
Areas to Watch
Trading at 16.4x book value
3.8% revenue growth
0.8% margin — thin
Operating margin of 1.7%
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -106.6% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, EPS Growth, Altman Z-Score. PEG of 0.61 suggests the stock is reasonably priced for its growth.
Bull Case : COSM
The strongest argument for COSM centers on Price/Book, Revenue Growth. Revenue growth of 30.7% demonstrates continued momentum.
Bear Case : COR
The primary concerns for COR are Price/Book, Revenue Growth, Profit Margin. Debt-to-equity of 3.65 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.
Bear Case : COSM
The primary concerns for COSM are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
COR profiles as a value stock while COSM is a hypergrowth play — different risk/reward profiles.
COSM carries more volatility with a beta of 4.12 — expect wider price swings.
COSM is growing revenue faster at 30.7% — sustainability is the question.
COR generates stronger free cash flow (1.2B), providing more financial flexibility.
Bottom Line
COR scores higher overall (64/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Cosmos Health Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?